Previous Article | Next Article 
Applied and Environmental Microbiology, January 2007, p. 344-346, Vol. 73, No. 1
0099-2240/07/$08.00+0 doi:10.1128/AEM.01328-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Shiga Toxin and Shiga Toxin-Encoding Phage Do Not Facilitate Escherichia coli O157:H7 Colonization in Sheep
Nancy A. Cornick,1*
Amy F. Helgerson,1 and
Vijay Sharma2
Department of Veterinary Microbiology and Preventative Medicine, Iowa State University, Ames, Iowa,1
Enteric Disease and Food Safety Research Unit, National Animal Disease Center, Ames, Iowa 500102
Received 9 June 2006/
Accepted 27 October 2006

ABSTRACT
Isogenic strains of
Escherichia coli O157:H7, missing either
stx2 or the entire Stx2-encoding phage, were compared with the
parent strain for their abilities to colonize sheep. The absence
of the phage or of the Shiga toxin did not significantly impact
the magnitude or duration of shedding of
E. coli O157:H7.

INTRODUCTION
The major reservoirs for Shiga toxin-producing
Escherichia coli (STEC) are cattle and other ruminants. These bacteria are carried
in the gastrointestinal tract and do not cause disease in mature
ruminants even when administered at very high doses (
2). It
is not known why the majority of ruminants are colonized by
STEC in contrast to other animal species. One of the major virulence
factors of STEC is Shiga toxin (Stx), an A
1B
5 toxin which is
encoded by lysogenic bacteriophages. The preferred receptor
for the toxin is globotriaosylceramide (Gb
3). It has been shown
that cattle lack Gb
3 receptors in their vascular endothelium,
and it is thought that this may protect them from the systemic
effects of Stx (
9,
14). It has also been proposed that Stx may
reduce the severities of viral infections such as bovine leukemia
virus (
4,
5) or modulate intestinal inflammation (
12) in cattle.
The objective of this study was to determine whether the Stx2-encoding bacteriophage or the Shiga toxin itself contributed to the magnitude or duration of colonization by E. coli O157:H7 in ruminants.
(A preliminary report of this work was presented at the symposium Beyond Antimicrobials, the Future of Gut Microbiology, Aberdeen, Scotland, 2002.)
The inoculum stains used in this study are listed in Table 1. Spontaneous nalidixic acid-, novobiocin-, and/or streptomycin-resistant mutants were selected from parent strain 86-24 and its isogenic derivatives. Strain 86-24 
933 was made as previously described by site-directed mutagenesis to delete stx2 (15). Some mutants not only lost the stx2 operon but suffered deletions in the region flanking the deleted stx2 operon, suggesting that these mutants may have lost the entire
933 phage. Loss of the phage was confirmed by a PCR assay that utilized several sets of primers (designed based on the published nucleotide sequence for
933 [13]) to amplify approximately 1-kb portions from different regions of the
933 genome. The loss of
933 in strain 86-24 
933 was also verified by challenging exponentially growing broth cultures of this strain and a
933-positive E. coli O157:H7 strain with subinhibitory amounts of norfloxacin (11). Inoculum strains were grown overnight in Trypticase soy broth and frozen in glycerol at 80°C until use.
All experiments complied with the Iowa State University Animal
Care and Use guidelines. Young adult sheep (4 to 12 months old,
80 to 120 lb) were purchased from a local source, housed two
per pen under biosafety level 2 conditions, and acclimated to
a diet of commercial sheep feed concentrate (1 lb/animal/day)
and alfalfa/grass hay ad libitum for 2 weeks prior to inoculation
as described previously (
1). Sheep were randomly divided into
three groups and inoculated with 10
10 CFU of either wild-type
E. coli O157:H7 (strain 86-24, six sheep), an isogenic
stx2 deletion mutant (strain TUV-86-2, eight sheep), or an isogenic
phage-cured mutant (strain 86-24


933, eight sheep). Fecal samples
were collected on days 2, 3, 4 (initial period), 13, 14, 15
(2 weeks), 28, 29, 30 (1 month), 58, 59, and 60 (2 months) postinoculation
(p.i.) and cultured for the inoculum strains. Briefly, 5 g of
fresh fecal pellets was diluted 1:5 in phosphate-buffered saline,
processed in a stomacher, and then serially diluted 10-fold
in phosphate-buffered saline. Dilutions (100 µl) were
spread onto selective medium as described previously (
1). A
10-g sample was also incubated overnight in enrichment broth
(100 ml Trypticase soy broth with 0.15% bile salts), concentrated
using immunomagnetic beads (Dynal Biotek, Oslo, Norway), and
cultured in selective medium. Data from individual sheep, collected
over each 3-day time period, were averaged together using geometric
means. Differences in the magnitudes of shedding between groups
of sheep were evaluated using repeated measures of analysis
of variance. A power analysis was used to determine the likelihood
of obtaining statistically significant results. This analysis
determined that using eight sheep per group would give an 80%
probability of detecting significant treatment differences (in
this case, strains) at
P values of

0.05.
A fourth group of eight sheep was dually inoculated with 1010 CFU of both the wild-type strain and the phage-cured mutant. Fecal samples were collected as described above and plated onto selective agar (1). Differences in the magnitudes of shedding between strains were evaluated using a paired t test. The competitive index (CI) was calculated using the formula CI = (X Y)/(X + Y), where X is the value for the phage-cured mutant and Y is that for the wild-type strain (10). All sheep were necropsied at 2 months p.i., and 5 g of tissue (rumen, ileum, Peyer's patch, cecum, spiral colon, and distal colon) was cultured in enrichment broth for 24 h, followed by immunomagnetic concentration and plating onto selective medium. We did not collect samples from the recto-anal junction since some of the animals in our study were necropsied prior to the description of this location as the primary colonization site of E. coli O157:H7.
Portions of the
933 phage were successfully amplified from the DNA of 86-24 containing
933 but not from the DNA of the 86-24 strain that had suffered a deletion of stx2 and the flanking region (data not shown). While cultures of strain 86-24 
933 exhibited normal exponential growth for several hours in the presence of norfloxacin, the isogenic parent strain experienced an abrupt decline in culture turbidity in the presence of norfloxacin (data not shown). The phase of abrupt decline in the culture turbidity of the parent strain correlates with phage induction and the release of phage particles due to bacterial cell lysis (17). The magnitudes of colonization by strain 86-24 and its isogenic mutants (TUV-86-2 and 86-24 
933) were not significantly different between any groups of sheep over the first 2 weeks of the experiment (Fig. 1). At 30 days p.i., E. coli O157:H7 was recovered from five of six sheep given the wild-type strain, from seven of eight sheep given the toxin mutant, and from two of eight sheep given the phage-cured mutant (<50 CFU/g). At necropsy (60 days p.i.), strain 86-24 was recovered from the feces of three of six sheep (<50 CFU/g) and from the ileum, spiral colon, and distal colon of one of those sheep. The stx2 deletion mutant was recovered from the ileum (102 CFU/cm), cecum, spiral colon, and distal colon (104 CFU/cm) of one of eight sheep. The phage-cured mutant was not recovered from any necropsy samples.
To corroborate whether the apparent difference in persistence
at 30 days p.i. between the phage-cured mutant and the other
two groups was biologically significant, another group of sheep
was dually inoculated with both the wild-type parent strain
and the phage-cured mutant. When both of these strains were
inoculated into the same animal, the absence of the phage did
not significantly inhibit or enhance either the magnitude or
the duration of colonization by
E. coli O157:H7 (Fig.
2). The
magnitude of shedding for both strains ranged from 60 to 3.5
x 10
6 CFU/g during the initial period p.i., from undetectable
to 1.8
x 10
3 CFU/g at 2 weeks p.i., from undetectable to 3
x 10
4 CFU/g at 1 month p.i., and from undetectable to <50 CFU/g
at 2 months p.i.. At the completion of the experiment (2 months
p.i.) both
E. coli O157:H7 strains were recovered from the feces
of two of eight sheep, and the phage-cured strain was recovered
from the feces of one additional animal. At necropsy, strain
86-24 was recovered from the ileum of one animal and the phage-cured
strain was not recovered from any tissues.
We were not able to demonstrate any significant differences
in the magnitudes or durations of colonization between wild-type
E. coli O157:H7, an isogenic
stx2 deletion mutant, and an isogenic
phage-cured mutant. However, our experiment was not designed
to identify the effects of Stx and the Stx-encoding phage in
trans. Since the majority of ruminants are colonized by STEC
at some point in their lives, it is likely that at least some
of our sheep carried STEC and that these strains could have
influenced the colonization of our inoculum strains. It has
been previously shown that a nontoxigenic
E. coli O157:H7 strain
colonized and persisted in weaned sheep (
18), and this occurrence
was observed more recently in cattle (
16). A pilot study of
weaned calves suggested that the presence of the Stx-encoding
phage may enhance colonization of
E. coli O157:H7 in ruminants
(
3). However, the number of animals in the pilot study was small,
and furthermore, isogenic strains of
E. coli O157:H7 were not
compared in either of the previous studies. Our work using a
competitive-colonization approach indicated that there was considerable
variability between individual animals (Fig.
2). For example,
on day 30 p.i., the phage-cured mutant was recovered in greater
numbers from four of eight sheep and the parent strain was recovered
in greater numbers from three of eight sheep. By day 60, equal
numbers of wild-type and phage-cured-mutant bacteria were recovered
from the majority of sheep (six of eight). This suggests that
the populations of individual
E. coli strains are constantly
in flux in vivo and that overall, the Stx2-encoding phage did
not influence the maintenance of STEC within the gastrointestinal
tract of mature sheep.

ACKNOWLEDGMENTS
We thank Erin Brown and Carisa Ralph for technical assistance
and Rich Evans for statistical advice.
This work was supported in part by the NRI Competitive Grants Program (00-02515).

FOOTNOTES
* Corresponding author. Mailing address: 2130 Vet Med Building, Iowa State University, Ames, IA 50010. Phone: (515) 294-6499. Fax: (515) 294-8500. E-mail:
ncornick{at}iastate.edu.

Published ahead of print on 3 November 2006. 

REFERENCES
1 - Cornick, N. A., S. L. Booher, T. A. Casey, and H. W. Moon. 2000. Persistent colonization of sheep by Escherichia coli O157:H7 and other E. coli pathotypes. Appl. Environ. Microbiol. 66:4926-4934.[Abstract/Free Full Text]
2 - Cray, W. C. J., and H. W. Moon. 1995. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61:1586-1590.[Abstract]
3 - Dean-Nystrom, E. A., B. T. Bosworth, H. W. Moon, and A. D. O'Brien. 1998. Bovine infection with Shiga toxin-producing Escherichia coli, p. 261-267. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, DC.
4 - Ferens, W. A., R. Cobbold, and C. J. Hovde. 2006. Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep. Infect. Immun. 74:2906-2916.[Abstract/Free Full Text]
5 - Ferens, W. A., and C. J. Hovde. 2000. Antiviral activity of Shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation. Infect. Immun. 68:4462-4469.[Abstract/Free Full Text]
6 - Franck, S. M., B. T. Bosworth, and H. W. Moon. 1998. Multiplex PCR for enterotoxigenic, attaching/effacing and Shiga toxin-producing Escherichia coli strains from calves. J. Clin. Microbiol. 36:1795-1797.[Abstract/Free Full Text]
7 - Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. Ann. Intern. Med. 109:705-712.[Abstract/Free Full Text]
8 - Gunzer, F., U. Bohn, S. Fuchs, I. Muhldorfer, J. Hacker, S. Tzipori, and A. Donhue-Rolfe. 1998. Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. Infect. Immun. 66:2337-2341.[Abstract/Free Full Text]
9 - Hoey, D. E., C. Currie, R. W. Else, A. Nutikka, C. A. Lingwood, D. L. Gally, and D. G. E. Smith. 2002. Expression of receptors for verotoxin 1 from Escherichia coli O157 on bovine intestinal epithelium. J. Med. Microbiol. 51:143-149.[Abstract/Free Full Text]
10 - Khachatryan, A. R., D. D. Hancock, T. E. Besser, and D. R. Call. 2004. Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves. Appl. Environ. Microbiol. 70:752-757.[Abstract/Free Full Text]
11 - Matsushiro, A., K. Sato, H. Miyamoto, T. Yamamura, and T. Honda. 1999. Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J. Bacteriol. 181:2257-2260.[Abstract/Free Full Text]
12 - Menge, C., M. Blessenohl, T. Eisenberg, I. Stamm, and G. Baljer. 2004. Bovine ileal intraepithelial lymphocytes represent target cells for Shiga toxin 1 from Escherichia coli. Infect. Immun. 72:1896-1905.[Abstract/Free Full Text]
13 - Plunkett, G. I., D. J. Rose, T. J. Durfee, and F. R. Blattner. 1999. Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J. Bacteriol. 181:1767-1778.[Abstract/Free Full Text]
14 - Pruimboom-Brees, I. M., T. W. Morgan, M. A. Ackermann, E. D. Nystrom, J. E. Samuel, N. A. Cornick, and H. W. Moon. 2000. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc. Natl. Acad. Sci. USA 97:10325-10329.[Abstract/Free Full Text]
15 - Sharma, V. K., and R. L. Zuerner. 2004. Role of hha and ler in transcriptional regulation of the esp operon of enterohemorrhagic Escherichia coli O157:H7. J. Bacteriol. 186:7290-7301.[Abstract/Free Full Text]
16 - Sheng, H., J. Y. Lim, H. J. Knecht, J. Li, and C. J. Hovde. 2006. Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect. Immun. 74:4685-4693.[Abstract/Free Full Text]
17 - Wagner, P. L., J. Livny, M. N. Neely, D. W. K. Acheson, D. I. Friedman, and M. K. Waldor. 2002. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol. Microbiol. 44:957-970.[CrossRef][Medline]
18 - Woodward, M. J., A. Best, K. A. Sprigings, G. R. Pearson, A. M. Skuse, A. Wales, C. M. Hayes, J. M. Roe, C. Low, and R. M. La Ragione. 2003. Nontoxigenic Escherichia coli O157:H7 strain NCTC12900 causes attaching-effacing lesions and eae-dependent persistence in weaned sheep. Int. J. Med. Microbiol. 293:299-308.[CrossRef][Medline]
Applied and Environmental Microbiology, January 2007, p. 344-346, Vol. 73, No. 1
0099-2240/07/$08.00+0 doi:10.1128/AEM.01328-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mellmann, A., Lu, S., Karch, H., Xu, J.-g., Harmsen, D., Schmidt, M. A., Bielaszewska, M.
(2008). Recycling of Shiga Toxin 2 Genes in Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:NM. Appl. Environ. Microbiol.
74: 67-72
[Abstract]
[Full Text]